Adn Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 22-05-2024
- Paid Up Capital ₹ 0.10 M
as on 22-05-2024
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2020)
- Net Worth -1740.72%
(FY 2020)
- Total Assets 27.79%
(FY 2020)
About Adn Laboratories
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Alok Aurovillian and Bhawani Aurovillian serve as directors at the Company.
- CIN/LLPIN
U74999PY2018PTC008335
- Company No.
008335
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Oct 2018
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pondicherry
Industry
Company Details
- Location
Pondicherry, Pondicherry, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Adn Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alok Aurovillian  | Managing Director | 08-Oct-2018 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bhawani Aurovillian | Director | 08-Oct-2018 | Current |
Financial Performance of Adn Laboratories.
Adn Laboratories Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 1740.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Adn Laboratories?
Unlock access to Adn Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Marcatus International Foods Private LimitedActive 13 years 2 monthsAlok Aurovillian is a mutual person
Alpha Organic Solutions Private LimitedActive 14 years 10 monthsAlok Aurovillian and Bhawani Aurovillian are mutual person
- International Agricultural Processing Private LimitedActive 26 years 9 months
Alok Aurovillian is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Adn Laboratories?
Unlock and access historical data on people associated with Adn Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adn Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adn Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
